INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.०१
arrow_upward
+१.०१%(+०.०१०) 1D
अक्टोबर २०, १३:४७:१३ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४७ करोड
Avg. vol.
२८.४५ लाख
Volume
१४.८३ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४७ करोड
Avg. vol.
२८.४५ लाख
Volume
१४.८३ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Barchart.com
·
१७ मिनेट पहिले
Kaplan Fox Announces a Securities Class Action Filed Against Alphabet Inc. (NASDAQ: GOOGL, GOOG) - Lead Plaintiff Deadline is December 1, 2026
Seeking Alpha
·
१४ मिनेट पहिले
This Is Not The Start Of The Feared Bear
Benzinga
·
४१ मिनेट पहिले
12 Industrials Stocks Moving In Tuesday's Intraday Session
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc